Risk factors for gastric cancer in patients with Lynch syndrome

Autores da FMUP

• Diogo Miguel Pereira Libânio Monteiro

  Autor

• Mário Jorge Dinis Ribeiro

  Autor

Participantes de fora da FMUP

• Ortigao, R
• Brito, M
• Pinto, C
• Sá, I
• Brandao, C

Unidades de investigação

• Medicina da Comunidade, Informação e Decisão em Saúde

Abstract

Introduction The cumulative lifetime risk of gastric cancer (GC) in patients with Lynch syndrome (LS) is reported to be 8%. There is limited evidence on specific risk factors for GC and no agreement among guidelines on gastric endoscopic surveillance schedule in LS patients. Aims and methods We conducted a retrospective cohort study to identify risk factors for gastric precancerous conditions (chronic atrophic gastritis and intestinal metaplasia) and GC in patients with LS and a case-control study to compare the prevalence of these conditions with a control group. Results We included 385 LS patients (40.5% male, mean age 49.0 years). During a median follow-up period of 48 months (interquartile range, 24-84 months), precancerous conditions were identified in 110 patients (34%) and the prevalence of advanced stages of atrophic gastritis was 3% for OLGA III/IV and 0.6% OLGIM III/IV. Family history of GC was significantly associated with OLGA III/IV (P = 0.020). Among LS patients, 10 patients (2.6%) were diagnosed with GC (incidence rate of 5/1000 persons-year). Older age and OLGA III/IV were identified as risk factors for GC (P < 0.001). When compared with controls, patients with LS had significantly higher rates of Hp infection (P = 0.035) and lower OLGA and OLGIM stages (P < 0.001 and P = 0.026, respectively). Conclusion In our cohort, the incidence of GC and advanced stages of atrophic gastritis was low. Older age and OLGA III/IV were associated with a higher risk of GC. Identification of risk factors for GC in LS patients can help tailoring endoscopic surveillance.

Copyright © 2022 Wolters Kluwer Health, Inc. All rights reserved.

Keywords

• endoscopy; gastric cancer; Lynch syndrome; precancerous conditions